News

BioAlliance Pharma’s Loramyc is now available in four European countries and will be commercialized in the UK, Germany and Denmark by SpeBio. With the UK, Germany and Denmark,

This new patent relates to a method of testing a drug or novel compound to determine its propensity for inducing cholestasis, a common toxic side effect of certain

Entelos’s DrugMatrix database is said to be a unique reference set of gene expression profiles for benchmark drugs and compounds that are linked to classic pharmacology, toxicology and

This approval follows a positive opinion from the European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use. CV Therapeutics’s Ranolazine is approved for use in Europe

Under the terms of the agreement, CompuMed will provide remote cardiac screening on an as needed basis for more than 30,000 detainees at the department’s correctional facilities statewide.

As part of the recapitalization, Trio becomes the first participating company in a series of strategic acquisitions by a partnership between Halifax, SV Life Sciences and an experienced

MacroChem’s product portfolio includes two clinical stage oncology products, 4-thio Ara-C, which is a next generation nucleoside analogue licensed from Southern Research Institute and sodium phenylbutyrate, which is

The new devices have received the FDA 510(k) clearance to market for the dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, and infra popliteal arteries, and for

Resveratrol, a key ingredient in Reversitall Plus and a compound found in grapes and enriched in red wine, has been found to lower cholesterol, improve circulation and facilitate